Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -219,879 | -167,575 | -155,101 | 109,195 | -67,485 |
| Depreciation Amortization | 311 | 306 | 310 | 93 | 53 |
| Accounts payable and accrued liabilities | -839 | -812 | -167 | -509 | -4,835 |
| Other Working Capital | 14,084 | -389 | -339 | 11,176 | -3,541 |
| Other Operating Activity | 30,573 | 23,167 | 21,022 | -246,619 | 32,375 |
| Operating Cash Flow | $-175,750 | $-145,303 | $-134,275 | $-126,664 | $-43,433 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -49 | N/A | -208 | -1,042 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 275,000 | N/A |
| Purchase Of Investment | -236,534 | -721,131 | -373,383 | -377,916 | -525,813 |
| Sale Of Investment | 416,572 | 584,817 | 409,397 | 352,933 | 192,038 |
| Investing Cash Flow | $179,989 | $-136,314 | $35,806 | $248,975 | $-333,775 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,825 | 2,375 | N/A |
| Common Stock Issued | 1,088 | 270,636 | 38,926 | 6,020 | 270,549 |
| Other Financing Activity | 0 | -4,448 | 0 | -34,328 | -1,765 |
| Financing Cash Flow | $1,088 | $266,188 | $40,751 | $-25,933 | $268,784 |
| Beginning Cash Position | 83,005 | 98,434 | 156,152 | 59,774 | 168,198 |
| End Cash Position | 88,332 | 83,005 | 98,434 | 156,152 | 59,774 |
| Net Cash Flow | $5,327 | $-15,429 | $-57,718 | $96,378 | $-108,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -175,750 | -145,303 | -134,275 | -126,664 | -43,433 |
| Capital Expenditure | -49 | N/A | -208 | -1,133 | 0 |
| Free Cash Flow | -175,799 | -145,303 | -134,483 | -127,797 | -43,433 |